A new Cochrane review bolsters confidence in the safety and effectiveness of RSV vaccines for older adults and pregnant ...

Respiratory syncytial virus (RSV) prefusion vaccines reduced RSV illness in older adults. When pregnant women received RSV F protein-based vaccines, their babies had fewer serious RSV illnesses. This ...

Susan Green developed a stubborn cough in December 2023. Nearly two years after contracting respiratory syncytial virus, or ...

Respiratory syncytial virus (RSV) continues to affect infants and older and immunocompromised people around the world. These ...

A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in ...

When Laura Ehrlich gave birth to her first child in 2020, the COVID-causing virus wasn’t the only threat facing her son. Born ...

Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, according to a new ...

Enanta Pharmaceuticals said on Monday its treatment for respiratory syncytial virus failed to shorten the time taken to reduce the severity of some symptoms, missing the primary goal of a mid-stage ...

The review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting groups ...

Tragic RSV vaccine trials in the 1960s set the field back for decades. Here’s how scientists finally made breakthroughs in ...

Bayo Curry-Winchell, MD explains why RSV can be dangerous to older adults. Washington turned down 170 custom license plates ...

The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over 2 seasons.